Profil
Thomas Littke is Head of Research and Development fro Speedel Pharma AG.
He joined Speedel in 2001 as Director of Clinical Operations.
Dr. Littke was a Senior Clinical Research Scientist at Takeda Corp., an International Medical Advisor at Novartis AG, and Director of Clinicaloperations at PRA International, Inc. He has experience in cardiovascular and metabolic diseases in the pharmaceutical industry.
Dr. Littke received an MD from the University of Freiburg, Germany.
Aktive Positionen von Thomas Littke
| Unternehmen | Position | Beginn |
|---|---|---|
Speedel Pharma AG
Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cardiovascular and metabolic diseases | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Thomas Littke
| Unternehmen | Position | Ende |
|---|---|---|
Takeda Corp.
Takeda Corp. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
Speedel Holding AG
Speedel Holding AG Pharmaceuticals: MajorHealth Technology Produces medicines | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Takeda Corp.
Takeda Corp. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Speedel Holding AG
Speedel Holding AG Pharmaceuticals: MajorHealth Technology Produces medicines | Health Technology |
Speedel Pharma AG
Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cardiovascular and metabolic diseases | Health Technology |
















